Nyxoah SA at Cantor Fitzgerald Global Healthcare Conference Transcript
Good morning. My name is Ross Osborn. I'm the medtech life science tools and diagnostics analyst at Cantor. And today, we have Olivier Taelman, CEO of Nyxoah.
Thank you.
Thank you for being here. So starting off, would you just provide a brief background on yourself?
Yes, brief background on myself. So as you can hear by my accent, I'm non-US. I'm coming from Belgium, Flemish speaking, studied biology, started working in the pharmaceutical industry for roughly 12 years. Eli Lilly was my first company, then Sanofi Aventis; switched into the medtech space, joining Medtronic. I was, for almost 11 years at Medtronic, always in neuromodulation, leading the European business.
After Medtronic, switched to Stryker Neurovascular, and then decided to leave the corporate life to go into the startup environment
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
